drugset / Trial / NCT02470026

Noradrenergic Activity, Cognition and Major Depressive Disorder

NCT02470026

Completed 131 enrolled Charite University, Berlin, Germany
RandomizedCrossoverDouble-blindBasic science

Summary

This study investigates influences of nordadrenergic activity on cognition in patients with major depression regarding influences of early life stress.

Timeline

Start
2014-06
Primary completion
2017-11
Completion
2018-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Yohimbine Small molecule